Researchers perform thousands of mutations to understand amyotrophic lateral sclerosis

Researchers have used a technique called high-throughput mutagenesis to study Amyotrophic Lateral Sclerosis (ALS), with unexpected results. Results showed that aggregation of TDP-43 is not harmful but actually protects cells, changing our understanding of ALS and opening the door to radically new therapeutic approaches.

Read more

New mechanism for dysfunctional insulin release identified

Researchers have identified a previously unknown mechanism that regulates release of insulin, a hormone that lowers blood glucose levels, from the beta cells of the pancreas. This mechanism is disrupted in type 2 diabetes. The scientists hope this finding will be used to develop new treatments against the disease.

Read more

New factor in the development of childhood lymphoma

The immune system is highly complex and a detailed understanding of many underlying mechanisms is still lacking. Only the precise interaction of a variety of factors guarantees a reliable and correct immune response in a healthy body. Misregulated immune responses are a major cause of a variety of diseases, including cancer, autoimmunity, and immune deficiency.

Read more

Interactions between bacteria and parasites

A team has completed the first study of the effects of a simultaneous infection with blood flukes (schistosomes) and the bacterium Helicobacter pylori — a fairly common occurrence in some parts of the world. They identified a complex interaction which resulted — among other effects — in a weakening of the adverse impact of the pathogens acting individually.

Read more

Scientists construct energy production unit for a synthetic cell

Scientists have constructed synthetic vesicles in which ATP, the main energy carrier in living cells, is produced. The vesicles use the ATP to maintain their volume and their ionic strength homeostasis. This metabolic network will eventually be used in the creation of synthetic cells – but it can already be used to study ATP-dependent processes.

Read more

Kidney disease: Senescent cell burden is reduced in humans by senolytic drugs

In a small safety and feasibility clinical trial, researchers have demonstrated for the first time that senescent cells can be removed from the body using drugs termed 'senolytics.' The result was verified not only in analysis of blood but also in changes in skin and fat tissue senescent cell abundance.

Read more